Gottlieb, A. B., Strober, B., Tha?i, D., Gordon, K., Kundu, S., Kisa, R., Wei, L., Banerjee, S. and Merola, J. (2020) “BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis as Assessed by the Static Physician’s Global Assessment (sPGA)/Body Surface Area (BSA) Composite Tool (sPGAxBSA), a Clinically Useful Alternative to PASI”, SKIN The Journal of Cutaneous Medicine, 4(5), p. s29. doi: 10.25251/skin.4.supp.29.